Literature DB >> 19237180

Presence of antibodies against Leishmania chagasi in haemodialysed patients.

Roberto Mascarenhas Souza1, Isaac Braullio Maia Delfino de Oliveira, Vinícius Câmara de Sousa Paiva, Kenio Costa Lima, Rivaldo Pereira dos Santos, José Bruno de Almeida, Kleber Giovanni Luz.   

Abstract

In the last decades there has been an increase in cases of visceral leishmaniasis complicating the post-transplant phase, mainly following kidney transplantation. The aim of this study was to evaluate the reactivity of haemodialysed patients using IFAT. Blood samples of 310 individuals from Natal, RN, Brazil, were collected and analysed. Data regarding blood transfusion, cause of end-stage renal disease and duration of haemodialysis were also analysed. In total, 69 patients (22.3%) were positive by IFAT. This study suggests that antibody detection should be performed in this group of patients since they are possible candidates for kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237180     DOI: 10.1016/j.trstmh.2009.01.003

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient.

Authors:  Nídia Marques; Manuela Bustorff; Anabela Cordeiro Da Silva; Ana Isabel Pinto; Nuno Santarém; Filipa Ferreira; Ana Nunes; Ana Cerqueira; Ana Rocha; Inês Ferreira; Isabel Tavares; Joana Santos; Elsa Fonseca; Conceição Moura; André Cerejeira; Júlia Vide; Jorge Cancela; Joana Sobrinho Simões; Susana Sampaio
Journal:  Pathogens       Date:  2020-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.